Renal Cancer - Results from #3000

Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis. February 4, 2020

Frequent KRAS Mutations in Oncocytic Papillary Renal Neoplasm with Inverted Nuclei. February 4, 2020

FGFR1 is associated with c-MYC and proangiogenic molecules in metastatic renal cell carcinoma under anti-angiogenic therapy. February 4, 2020

Mean platelet volume-to-lymphocyte ratio: a novel biomarker associated with overall survival in patients with nonmetastatic clear cell renal cell carcinoma treated with nephrectomy. February 3, 2020

Targeting PD-1 or PD-L1 in Metastatic Kidney Cancer - Combination Therapy in the First Line Setting. February 3, 2020

Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities. February 3, 2020

Percutaneous Microwave Ablation versus Laparoscopic Partial Nephrectomy for cT1a Renal Cell Carcinoma: A Propensity-matched Cohort Study of 1955 Patients. January 31, 2020

LncRNA PCGEM1 promotes renal carcinoma progression by targeting miR-433-3p to regulate FGF2 expression. January 31, 2020

Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data. January 31, 2020

Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset. January 30, 2020

Systematic investigation of the prognostic value of cell division cycle-associated proteins for clear cell renal cell carcinoma patients. January 30, 2020

Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers. January 30, 2020

Overexpression of PPT2 Represses the Clear Cell Renal Cell Carcinoma Progression by Reducing Epithelial-to-mesenchymal Transition. January 29, 2020

Development and validation of a robust multigene signature as an aid to predict early relapse in stage I-III clear cell and papillary renal cell cancer. January 29, 2020

Effect of obesity and overweight status on complications and survival after minimally invasive kidney surgery in patients with clinical t2 renal masses. January 29, 2020

Renal Function Impairment Below Safety Limits Correlates With Cancer-specific Mortality in Localized Renal Cell Carcinoma: Results From a Single-center Study. January 28, 2020

Prognostic value of downregulated 5-hydroxymethylcytosine expression in renal cell carcinoma: a 10 year follow-up retrospective study. January 28, 2020

Survival benefit with extended lymphadenectomy for advanced renal malignancy: A population-based analysis. January 28, 2020

Interleukin-2 chronotherapy for metastatic renal cell carcinoma: Results of a phase I-II study. January 27, 2020

Real-World Assessment of Clinical Outcomes Among First-Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group. January 27, 2020

Page 151 of 456